| 1 | PFE | Pfizer Inc. | 7.52% |
| 2 | JNJ | Johnson & Johnson | 7.36% |
| 3 | ABBV | AbbVie Inc. | 7.19% |
| 4 | MRK | Merck & Co., Inc. | 7.02% |
| 5 | BMY | Bristol-Myers Squibb Company | 6.27% |
| 6 | VTRS | Viatris Inc. | 3.86% |
| 7 | GILD | Gilead Sciences, Inc. | 3.86% |
| 8 | AMGN | Amgen Inc. | 3.76% |
| 9 | BIIB | Biogen Inc. | 3.71% |
| 10 | ZTS | Zoetis Inc. | 3.66% |
| 11 | UTHR | United Therapeutics Corporation | 3.61% |
| 12 | LLY | Eli Lilly and Company | 3.31% |
| 13 | REGN | Regeneron Pharmaceuticals, Inc. | 3.09% |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 3.02% |
| 15 | EXEL | Exelixis, Inc. | 2.38% |
| 16 | ELAN | Elanco Animal Health Incorporated | 2.37% |
| 17 | CRL | Charles River Laboratories International, Inc. | 2.19% |
| 18 | ILMN | Illumina, Inc. | 2.02% |
| 19 | MEDP | Medpace Holdings, Inc. | 1.92% |
| 20 | OGN | Organon & Co. | 1.87% |
| 21 | NBIX | Neurocrine Biosciences, Inc. | 1.64% |
| 22 | HALO | Halozyme Therapeutics, Inc. | 1.41% |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 1.11% |
| 24 | ALKS | Alkermes plc | 1.05% |
| 25 | PRGO | Perrigo Company plc | 0.95% |
| View FTXH holdings |
